Literature DB >> 6265489

Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome.

R A Lobo, U Goebelsmann.   

Abstract

Congenital adrenal hyperplasia due to 3 beta-ol-hydroxysteroid dehydrogenase (3 beta-ol) deficiency is usually lethal. A partial deficiency in 3 beta-ol has been suggested in some women presenting with androgen excess. In this study, 24 women were investigated who had hirsutism and oligomenorrhea and high serum delta 5 androgens compared to delta 4 androgens. Of these women, 9 had significantly elevated 17-hydroxypregnenolone (17 Preg) to 17-hydroxyprogesterone (17 Prog) ratios when compared to controls under basal conditions. On further testing of 9 women with ACTH, 4 had significantly elevated 17 Preg to 17 Prog ratios. Eight women had elevated ratios of dehydroepiandrosterone sulfate to androstenedione, 4 had elevations of androstenediol (Adiol) to testosterone (T), and 4 had abnormal 17 Preg to cortisol ratios. Only 3 women out of the original 24 selected for study had elevated ratios for all 4 different steroid pairs measured. 17 Prog was normal in these women with 3 beta-ol deficiency in contradistinction to the high levels normally observed in women with congenital adrenal hyperplasia due to 21- or 11-hydroxylase deficiency. It is suggested that the cause of androgen excess in these women is high circulating levels of Adiol and, in part, the slightly elevated unbound T levels in these women. In conclusion, a subtle, incomplete form of 3 beta-ol deficiency may exist in adult women and is manifest by high delta 5 androgens such as dehydroepiandrosterone sulfate and Adiol and normal delta 4 androgens such as androstenedione and T.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265489     DOI: 10.1210/jcem-53-2-394

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

2.  Long-term infertility in late-onset 3 beta-ol-dehydrogenase deficiency: successful pregnancy following dexamethasone and in vitro fertilization (IVF) therapy.

Authors:  N Rojansky; A Shushan; A Rosler; D Weinstein; N Laufer
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-10

Review 3.  The next 150 years of congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2015-06-03       Impact factor: 4.292

Review 4.  Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome.

Authors:  E Carmina; R A Lobo
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

5.  Late-onset congenital adrenal hyperplasia in a group of hyperandrogenic women.

Authors:  D K Hassíakos; J P Toner; G S Jones; H W Jones
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

6.  Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients.

Authors:  E Carmina; F Rosato; A Jannì
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

Review 7.  Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome.

Authors:  Márcia Marly Winck Yamamoto; Sebastião Freitas de Medeiros
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

8.  Assessment of the one hour adrenocorticotrophic hormone test in the diagnosis of attenuated 21-hydroxylase deficiency.

Authors:  V T Innanen; J M Vale
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

9.  Pituitary and adrenal response to ovine corticotropin-releasing hormone in women with polycystic ovarian syndrome.

Authors:  A Mongioì; M Macchi; E Vicari; M C Fornito; A E Calogero; C Riccioli; G Minacapilli; M L Moncada; R D'Agata
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

10.  Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women.

Authors:  Sebastião Freitas de Medeiros; Cinthia Marenza Ormond; Matheus Antônio Souto de Medeiros; Nayara de Souza Santos; Camila Regis Banhara; Márcia Marly Winck Yamamoto
Journal:  Endocr Connect       Date:  2017-08-07       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.